|Articles|September 1, 2013
- Applied Clinical Trials-09-01-2013
- Volume 22
- Issue 9
ACT Insert Cover
S
Advertisement
Cover
Articles in this issue
almost 13 years ago
Electronic Data Capture in Clinical Trialsalmost 13 years ago
Japan Relaxes Clinical Trial Regulations; China Still Strictalmost 13 years ago
The Shift to a Centralized Lab Approachalmost 13 years ago
Business and People September 2013almost 13 years ago
Translational Medicine and Biomarkersalmost 13 years ago
FDA, Research Organizations Seek to Bolster Drug Submissionsalmost 13 years ago
Suicidal Ideation and Behavior: We Can Make a Differencealmost 13 years ago
ACT Coveralmost 13 years ago
Streamline and Improve Study Start-Upalmost 13 years ago
Right Time, Right ChannelAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
2
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
3
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5